Acetaminophen is the top US cause of acute liver failure, nearly all from overdose

Acetaminophen — paracetamol — sits on an unusual double edge. At recommended doses it is one of the best-tolerated painkillers there is, which is why it is in so many homes. Yet it is also the single leading cause of acute liver failure in the United States, and that harm is overwhelmingly a story of overdose rather than of ordinary use [s1] [s2]. The distinction between those two facts is the whole point, and it is easy to lose.

The scale of the harm

The clearest measurement comes from a prospective study, published in Hepatology, that tracked consecutive acute liver failure patients at 22 tertiary care centres across the US over six years [s1]. Of 662 patients who met strict criteria for acute liver failure, 275 — 42% — were caused by acetaminophen [s1]. The trend was rising over the study: the annual share of acute liver failure attributable to acetaminophen climbed from 28% in 1998 to 51% in 2003 [s1]. The authors' summary is blunt — acetaminophen hepatotoxicity far exceeds other causes of acute liver failure in the United States [s1].

Acute liver failure is the severe end: coagulopathy and confusion from a liver that has stopped working. Of the acetaminophen cases, 65% survived, 27% died without a transplant, and 8% underwent liver transplantation [s1]. This is not a minor or theoretical injury.

Why "at recommended doses it's safe" and "leading cause of liver failure" are both true

The reconciliation is dose. The NIH's LiverTox resource describes acetaminophen hepatotoxicity as most commonly arising after a suicide attempt using more than 7.5 grams — and generally more than 15 grams — well above the doses on any label [s2]. It notes that at therapeutic doses the drug can cause transient, self-resolving rises in liver enzymes, and that intake above roughly 4 grams daily has been found to produce such transient elevations in a proportion of people; but the leap to liver failure is a feature of large overdoses, not of recommended use [s2]. The numbers here describe the toxicology; they are not a dosing instruction, which is a matter for the product label and a pharmacist or clinician.

That is the resolution of the apparent paradox. A drug can be genuinely safe within its intended range and still be a top cause of liver failure, if enough people exceed that range — by intent or by accident.

The accidental half is the important part

The finding that should change how a reader thinks about the drug is this: nearly half of the acetaminophen liver-failure cases were not suicide attempts. In the study, unintentional overdoses accounted for 131 cases (48%), intentional overdoses 122 (44%), and 22 (8%) were of unknown intent [s1]. The median amount ingested across the cases was 24 grams — the equivalent of 48 extra-strength tablets [s1]. Crucially, the transplant-free survival and transplant rates were similar between the intentional and unintentional groups: an accidental overdose is not a milder event than a deliberate one [s1].

What produced the accidental cases is the actionable detail. Among the unintentional overdoses, 38% had taken two or more different acetaminophen preparations at the same time, and 63% had used narcotic–acetaminophen combination products [s1]. Eighty-one percent had been taking acetaminophen or other analgesics for acute or chronic pain [s1]. The mechanism of accidental harm, in other words, is often invisible: a person treating pain takes a combination painkiller and a separate acetaminophen product without realising both contain the same drug, and the doses stack. Acetaminophen is a hidden ingredient in many cold, flu and combination-pain products, and the study's own recommendation was to educate patients, physicians and pharmacies to limit these high-risk situations [s1].

The limits of what this says

Two caveats keep this honest. First, the headline figures come from tertiary referral centres treating the sickest patients, so they describe the severe end of the spectrum, not the everyday experience of the drug — most people who take acetaminophen as directed never come near liver injury [s1] [s2]. Second, individual susceptibility varies; factors such as heavy alcohol use, malnutrition and taking staggered doses over several days can matter, which is one reason dosing questions belong with a clinician or pharmacist rather than a general article [s2]. What the evidence does establish cleanly is the shape of the risk: concentrated at high total doses, frequently reached by accident through combined products, and severe when it happens.

What this leaves a reader with

Acetaminophen is both a well-tolerated painkiller at recommended doses and the leading cause of acute liver failure in the US — because the failures come from overdose, and roughly half of those are unintentional, often from unknowingly combining products that contain it [s1] [s2]. The single most useful habit the data points to is knowing which products contain acetaminophen before taking more than one, and treating dosing questions as something to check with a pharmacist or clinician.

This article is informational and is not medical advice, and does not provide dosing guidance.

Sources

• Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study — Hepatology (AASLD), 2005-12-01
• Acetaminophen (LiverTox: Clinical and Research Information on Drug-Induced Liver Injury) — National Institute of Diabetes and Digestive and Kidney Diseases (NIH)